PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8209127

[Polymerase chain reaction: basic principles].

D F Schorderet
View original source ↗Export metadata ↓

Abstract

The Polymerase Chain Reaction is a technique in molecular biology, that allows million-fold amplification of DNA-fragments. It is based on specific oligonucleotides used as starting segments (primers) of both sides of the genomic region to be studied. This chain reaction is characterized by three steps: denaturation of DNA by increasing the temperature; renaturation of the DNA allowing for competition between the two original DNA segments and the numerous primers, and finally synthesis of DNA by the polymerase. The cycle is repeated from 25 to 35 times in order to exponentially duplicate the DNA-fragments between the two primers. Usage of a thermoresistant polymerase permitted automatization of the procedure. This technique represents a revolution for practical molecular biology and medicine. Its very high sensitivity, however, may cause errors that have to be recognized. Several practical examples are described and analyzed in order to illustrate the PCR-concept to physicians in practise.

Explore related subjects

Base SequenceDNA PrimersDNA ReplicationHumansMolecular Sequence DataNucleic Acid DenaturationNucleic Acid HybridizationNucleic Acid RenaturationPolymerase Chain ReactionEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D F Schorderet. 1994-05-17. [Polymerase chain reaction: basic principles].. https://pubmed.ncbi.nlm.nih.gov/8209127/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2016

miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin.

Although progress in clinical and basic research has significantly increased our understanding of breast cancer, little is known about the molecular mechanism underlying breast cancer metastasis. Identification of effective therapeutic targets to prevent breast cancer metastasis is urgently needed. The function of miR-503-3p has been investigated in other cancers, but its role in breast cancer remains undefined. Here, we found that miR-503-3p was overexpressed in breast cancer tissue and plasma compared with adjacent normal breast tissue and with plasma from healthy individuals. Moreover, we identified miR-503-3p to be an oncogene of breast cancer cell proliferation, migration and invasion. Upregulation of miR-503-3p in breast cancer cells inhibited expression of epithelial-mesenchymal transition (EMT)-related protein SMAD2 and the epithelial marker protein E-cadherin by directly binding to their mRNA 3' untranslated region, whereas increased expression of mesenchymal marker proteins, including vimentin and N-cadherin. Taken together, our findings support a critical role for miR-503-3p in induction of breast cancer EMT and suggest that plasma miR-503-3p may be a useful diagnostic biomarker for breast cancer.

Base Sequence↗
PubMed2003

Identification and characterization of Prp45p and Prp46p, essential pre-mRNA splicing factors.

Through exhaustive two-hybrid screens using a budding yeast genomic library, and starting with the splicing factor and DEAH-box RNA helicase Prp22p as bait, we identified yeast Prp45p and Prp46p. We show that as well as interacting in two-hybrid screens, Prp45p and Prp46p interact with each other in vitro. We demonstrate that Prp45p and Prp46p are spliceosome associated throughout the splicing process and both are essential for pre-mRNA splicing. Under nonsplicing conditions they also associate in coprecipitation assays with low levels of the U2, U5, and U6 snRNAs that may indicate their presence in endogenous activated spliceosomes or in a postsplicing snRNP complex.

Base Sequence↗
PubMed1997

Precise branch point mapping and quantification of splicing intermediates.

Lariat intermediates of a group II intron were investigated via RT-PCR. Several reverse transcriptases appeared capable of reading through a branched nucleotide. A new method has been established that yields precise information about the location of the branch point within an intron. As an extension of our approach, antisense transcripts of the previously cloned PCR products were successfully used in RNase Protection Assays, providing a tool for quantification of splicing intermediates. Application of the method presented to other self-splicing introns as well as introns in nuclear pre-mRNAs is envisaged.

Base Sequence↗